For the year ending 2025-12-31, GCAN had -$56,553 decrease in cash & cash equivalents over the period.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income (loss) | -331,612 |
| Loss on conversion of notes payable | 227,756 |
| Amortization of right of first refusal agreement | 417 |
| Forgiveness of debt | 80,776 |
| Issuance of common stock for compensation | 1,800 |
| Issuance of common stock for accrued compensation | 10,000 |
| Issuance of series b preferred stock for accrued compensation | 20,000 |
| Accounts payable | 635 |
| Accrued interest | 1,627 |
| Accrued officer compensation | 90,000 |
| Net cash used in operating activities | -60,153 |
| Proceeds from loans, related party | 3,600 |
| Net cash provided by financing activities | 3,600 |
| Net (decrease) in cash | -56,553 |
| Cash balance, beginning of period | 57,368 |
| Cash balance, end of period | 815 |
Greater Cannabis Company, Inc. (GCAN)
Greater Cannabis Company, Inc. (GCAN)